Patents

US 12559463 B2: Crystalline forms of a JAK2 inhibitor

Granted
2026-02-24
Filed
2020-02-11 application 17430188
Type
Utility · 22 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present disclosure provides crystalline forms of a JAK2 inhibitor, compositions thereof and methods of treating a JAK2-mediated disorder.

Source: PTBLXML, file of 2026-02-24 (ipgb20260224.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
IMPACT BIOMEDICINES INC. 3 patentsUS company or organizationPrinceton, NJIMPACT BIOMEDICINES, INC. State business registration EXACT high confidence: identical full name and statePTBLXML, file of 2026-02-24

Inventors

InventorPlacePatentsPerson pageSource
Lianfeng HuangBasking Ridge, NJPTBLXML, file of 2026-02-24
Nancy TsouEdison, NJPTBLXML, file of 2026-02-24
Wenju WuWarren, NJPTBLXML, file of 2026-02-24
Daozhong ZouRaritan, NJPTBLXML, file of 2026-02-24

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D239/48PTBLXML, file of 2026-02-24
C07BGeneral methods of organic chemistry; apparatus thereforC07B2200/13PTBLXML, file of 2026-02-24

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.